T-cell acute lymphoblastic leukemia (T-ALL) is a hematological malignancy in need of novel therapeutic approaches.
Here, we identify ATP-citrate lyase (ACLY) as overexpressed in human T-ALL and as a promising therapeutic target for its treatment.
To test the effects of ACLY in leukemia progression, we developed an isogenic model of NOTCH1-induced
